Marked geographic aggregation of acute intermittent porphyria families carrying mutation Q180X in Venezuelan populations, with description of further mutations

scientific article published on October 27, 2010

Marked geographic aggregation of acute intermittent porphyria families carrying mutation Q180X in Venezuelan populations, with description of further mutations is …
instance of (P31):
scholarly articleQ13442814

External links are
P6179Dimensions Publication ID1049002148
P356DOI10.1007/S10545-010-9228-X
P698PubMed publication ID20978940

P2093author name stringIrene Paradisi
Sergio Arias
P2860cites workStructure of human porphobilinogen deaminase at 2.8 A: the molecular basis of acute intermittent porphyriaQ27653713
May 2006 update in porphobilinogen deaminase gene polymorphisms and mutations causing acute intermittent porphyria: comparison with the situation in Slavic populationQ28288056
The CpG dinucleotide and human genetic diseaseQ28296311
Quantitative analysis of SMN1 gene and estimation of SMN1 deletion carrier frequency in Korean population based on real-time PCRQ33629502
Heme biosynthesis in intermittent acute prophyria: decreased hepatic conversion of porphobilinogen to porphyrins and increased delta aminolevulinic acid synthetase activityQ33708953
Recommendations for the diagnosis and treatment of the acute porphyriasQ33985744
Finishing touches: post-translational modification of protein factors involved in mammalian pre-mRNA 3' end formationQ34777700
Acute porphyrias in the Argentinean population: a review.Q35191975
Molecular epidemiology and diagnosis of PBG deaminase gene defects in acute intermittent porphyriaQ35250368
A systematic analysis of disease-associated variants in the 3' regulatory regions of human protein-coding genes I: general principles and overviewQ36463097
Porphyria in SwedenQ36734856
Acute intermittent porphyria caused by an arginine to histidine substitution (R26H) in the cofactor-binding cleft of porphobilinogen deaminaseQ38317060
A rapid non-enzymatic method for the preparation of HMW DNA from blood for RFLP studiesQ40507676
Haplotype analysis of Norwegian and Swedish patients with acute intermittent porphyria (AIP): Extreme haplotype heterogeneity for the mutation R116W.Q41920086
A simple and nonradioactive method for detecting the Rb1.20 DNA polymorphism in the retinoblastoma geneQ43146253
Liver transplantation for acute intermittent porphyria: a viable treatment?Q43172810
Evidence for an ancestral founder of the common R116W mutation in the hydroxymethylbilane synthase gene in acute intermittent porphyria in The Netherlands.Q43298235
Porphobilinogen deaminase gene in African and Afro-Caribbean ethnic groups: mutations causing acute intermittent porphyria and specific intragenic polymorphismsQ43934792
Acute intermittent porphyria in Sweden. Molecular, functional and clinical consequences of some new mutations found in the porphobilinogen deaminase geneQ44173479
Ancestral founder of mutation W283X in the porphobilinogen deaminase gene among acute intermittent porphyria patients.Q44302301
Molecular analysis of acute intermittent porphyria: mutation screening in 20 patients in Germany reveals 11 novel mutationsQ44788415
An analysis of 112 acute porphyric attacks in Cape Town, South Africa: Evidence that acute intermittent porphyria and variegate porphyria differ in susceptibility and severityQ45219213
Huntington disease mutation in Venezuela: age of onset, haplotype analyses and geographic aggregationQ45307339
Acute intermittent porphyria--impact of mutations found in the hydroxymethylbilane synthase gene on biochemical and enzymatic protein propertiesQ45775369
Porphyria in Switzerland, 15 years experienceQ45836537
Hereditary hepatic porphyrias in FinlandQ46244153
Detection of a R173W mutation in the porphobilinogen deaminase gene in the Nova Scotian "foreign Protestant" population with acute intermittent porphyria: a founder effectQ46376502
HMBS mutations in Chinese patients with acute intermittent porphyria.Q51444444
The hepatic porphyrias: experience with 105 casesQ67875866
Detection of four mutations in six unrelated South African patients with acute intermittent porphyriaQ71201178
Phenotypic and population features of MPS IH in Quibor, VenezuelaQ71643967
A modified spectrophotometric assay for porphobilinogen deaminase: its application in the detection of both carriers and patients with acute intermittent porphyriaQ71925329
Acute intermittent porphyria in Finland: 19 mutations in the porphobilinogen deaminase geneQ72253560
The occurrence and determination of delta-amino-levulinic acid and porphobilinogen in urineQ73933517
Comparison of complementary and genomic DNA sequencing for the detection of mutations in the HMBS gene in British patients with acute intermittent porphyria: identification of 25 novel mutationsQ78147289
Novel HMBS founder mutation and significant intronic polymorphism in Spanish patients with acute intermittent porphyriaQ80831939
PorphyriasQ81277608
PorphyriasQ83185413
P407language of work or nameEnglishQ1860
P921main subjectacute intermittent porphyriaQ424247
single-nucleotide polymorphismQ501128
P304page(s)S455-63
P577publication date2010-10-27
P1433published inJournal of Inherited Metabolic DiseaseQ6295359
P1476titleMarked geographic aggregation of acute intermittent porphyria families carrying mutation Q180X in Venezuelan populations, with description of further mutations
P478volume33 Suppl 3

Reverse relations

cites work (P2860)
Q35039960Acute intermittent porphyria associated with respiratory failure: a multidisciplinary approach
Q47923220GBA mutations in Gaucher type I Venezuelan patients: ethnic origins and frequencies
Q34457673Seven Novel Mutations in Bulgarian Patients with Acute Hepatic Porphyrias (AHP).
Q41148958Spinocerebellar ataxias in Venezuela: genetic epidemiology and their most likely ethnic descent

Search more.